Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome

被引:80
|
作者
Lee, JH
Lee, JH
Shin, YR
Lee, JS
Kim, WK
Chi, HS
Park, CJ
Seo, EJ
Lee, KH
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Med,Songpa Gu, Seoul 138040, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Pathol, Seoul 138040, South Korea
关键词
prognosis; classification; MDS;
D O I
10.1038/sj.leu.2402798
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We retrospectively studied 227 patients with MDS (1) to identify the prognostic factors of survival and acute leukemia evolution in Korean patients with MDS, (2) to apply different prognostic scoring systems to the same group of patients, and (3) to compare the FAB with the WHO classification. Six scoring systems were applied to the patients, and the FAB and WHO classifications were compared. The patients' median age was 57 years. The median survival time was 21 months, and age, dysgranulopoiesis and the IPSS cytogenetic groups were independent prognostic factors for survival. Acute leukemia occurred in 34 patients, and the cumulative incidence was 27.1% at 3 years. Marrow blast percentage was the only independent prognostic factor for acute leukemia evolution. Most scoring systems successfully discriminated risk groups for survival and acute leukemia evolution, but patient distribution into risk groups varied according to the scoring systems. Refractory cytopenia with multilineage dysplasia and RAEB II seemed to have different prognoses from RA or RARS and RAEB I, respectively. In summary, our MDS patients had different disease natures from those of Western countries regarding clinical features, prognostic factors and cytogenetic profiles. Although the WHO classification seems to improve the FAB classification, further studies are warranted to validate the utility of the WHO classification before it is accepted for routine clinical use. Our study has the limitations of retrospective analysis, and our results should be verified in future prospective studies.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 50 条
  • [1] Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome
    J-H Lee
    J-H Lee
    Y-R Shin
    J-S Lee
    W-K Kim
    H-S Chi
    C-J Park
    E-J Seo
    K-H Lee
    [J]. Leukemia, 2003, 17 : 305 - 313
  • [2] Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems
    Bektas, Ozlen
    Uner, Aysegul
    Eliacik, Eylem
    Uz, Burak
    Isik, Ayse
    Etgul, Sezgin
    Bozkurt, Sureyya
    Haznedaroglu, Ibrahim Celalettin
    Goker, Hakan
    Sayinalp, Nilgun
    Aksu, Salih
    Demiroglu, Haluk
    Ozcebe, Osman Ilhami
    Buyukasik, Yahya
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 119 - 126
  • [3] Comparison of five prognostic scoring systems, the French–American–British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: results of a single-center analysis
    H. Müller-Berndorff
    P. S. Haas
    R. Kunzmann
    J. Schulte-Mönting
    M. Lübbert
    [J]. Annals of Hematology, 2006, 85 : 502 - 513
  • [4] Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes:: results of a single-center analysis
    Mueller-Berndorff, H.
    Haas, P. S.
    Kunzmann, R.
    Schulte-Moenting, J.
    Luebbert, M.
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 (08) : 502 - 513
  • [5] Application of Newly Developed IPSS-M and Comparison of Different Prognostic Systems in Patients with Myelodysplastic Syndrome
    Ma, Jiale
    Wei, Yanhui
    Wang, Xuee
    Wang, Peixuan
    Song, Chunhua
    Ge, Zheng
    [J]. BLOOD, 2022, 140 : 9791 - 9792
  • [6] Improvement of the WHO classification-based prognostic scoring system (WPSS) by including age for Korean patients with the myelodysplastic syndrome
    Kim, Sung-Hyun
    Lee, Ji Hyun
    Choi, Jimin
    Kwon, Kyung A.
    Lee, Suee
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Han, Jin-Yeong
    Kim, Hyo-Jin
    [J]. LEUKEMIA RESEARCH, 2010, 34 (12) : 1589 - 1595
  • [7] Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications
    Lorand-Metze, I
    Pinheiro, MP
    Ribeiro, E
    de Paula, EV
    Metze, K
    [J]. LEUKEMIA RESEARCH, 2004, 28 (06) : 587 - 594
  • [8] VALIDATION OF DIFFERENT PROGNOSTIC CLASSIFICATIONS IN PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROME (MDS) IN THE NEW MILLENIUM
    Vazquez, I.
    Borras, J. B.
    Mascaro, M.
    Romero, P.
    Del Campo, R.
    Cladera, A.
    Guerra, J. M.
    Gomez, D.
    Gonzalez, E.
    Serra, F.
    Bargay, J.
    [J]. HAEMATOLOGICA, 2014, 99 : 625 - 625
  • [9] A clinical study of pediatric Myelodysplastic syndrome: Application of international prognostic scoring system and the review of the literature in Korean patients.
    Kim, CJ
    Kook, H
    Yoon, WS
    Ryu, NE
    Hwang, TJ
    [J]. BLOOD, 1999, 94 (10) : 284B - 284B
  • [10] Application and Comparison of Different Prognostic Scoring Systems in Patients Who Underwent Cardiologist-Managed Percutaneous Cardiopulmonary Support
    Chien, Shih-Chieh
    Lan, Wei-Ren
    Wu, Shu-Hao
    Chien, Chen-Yen
    Chien, Yu-Shan
    Lo, Chi-In
    Tsai, Cheng-Ting
    Chen, Chun-Yen
    [J]. ACTA CARDIOLOGICA SINICA, 2020, 36 (04) : 326 - 334